84 related articles for article (PubMed ID: 3167971)
1. [Immunologic abnormalities in HIV seropositivity].
Kamínková J; Havlík J
Cas Lek Cesk; 1988 Aug; 127(32):1011-3. PubMed ID: 3167971
[No Abstract] [Full Text] [Related]
2. [Correlation between serum p24 antigen and the isolation of human immunodeficiency virus (HIV) from the lymphocytes of subjects with HIV infection].
Angarano G; Fiore JR; Casalino C; Monno L; Esposito M; Pastore G
Boll Soc Ital Biol Sper; 1988 Aug; 64(8):739-45. PubMed ID: 3214574
[No Abstract] [Full Text] [Related]
3. Recent advances in cellular aberrations in the acquired immune deficiency syndrome.
Tsang PH; Roboz JP; Bekesi JG
J Exp Pathol; 1987; 3(4):633-51. PubMed ID: 3331651
[No Abstract] [Full Text] [Related]
4. [The role of Langerhans cells in acquired immunologic deficiency syndrome].
Belsito DV; Baer RL; Thorbecke GJ
Hautarzt; 1988 Aug; 39(8):487-90. PubMed ID: 3065291
[No Abstract] [Full Text] [Related]
5. Detection and characterization of circulating immune complexes in HIV-related diseases.
Carini C; D'Amelio R; Mezzaroma I; Aiuti F
Diagn Clin Immunol; 1987; 5(3):135-9. PubMed ID: 3480082
[TBL] [Abstract][Full Text] [Related]
6. Immunologic developments in AIDS--1984.
Jacobs JL; Murray HW
Year Immunol; 1985; ():208-13. PubMed ID: 3939623
[No Abstract] [Full Text] [Related]
7. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
[TBL] [Abstract][Full Text] [Related]
8. [The relevance of phenotypic markers for progression in AIDS in HIV-1+ children].
Zugun F; Sfartz S; Carasevici E
Bacteriol Virusol Parazitol Epidemiol; 1995; 40(3-4):253-6. PubMed ID: 8640013
[No Abstract] [Full Text] [Related]
9. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
10. A clinical-immunological evaluation of AIDS cases and related syndromes.
Gritti FM; Raise E; Gualandi G; Bonazzi L; Martuzzi M; Schiattone ML; Di Pede B; Gallo R; Rivano MT; Taruscio D
J Exp Pathol; 1987; 3(4):723-36. PubMed ID: 3483882
[TBL] [Abstract][Full Text] [Related]
11. [Immunological abnormalities in intravenous drug addicts in relation to contact with the HTLV III/LAV virus].
Besalduch Vidal J; Sanchís Cervera J; Miralles Bacete E; Vila Pastor B; Balaguer Muñoz H; Gil García S
Med Clin (Barc); 1987 May; 88(18):715-8. PubMed ID: 3497319
[No Abstract] [Full Text] [Related]
12. [Cleavage of the C3 component of complement in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)].
Andreev SV; Ishchenko AM; Pasechnik VA; Ketlinskiĭ SA; Karamov EV
Dokl Akad Nauk SSSR; 1987; 296(5):1266-8. PubMed ID: 3428115
[No Abstract] [Full Text] [Related]
13. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic follow-up of HIV-positive patients. C3, C4 complement components during HIV infection].
Skokanová V; Kamínková J; Vacek Z; Stanková M
Cas Lek Cesk; 1993 Sep; 132(17):526-8. PubMed ID: 8402822
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of high-avidity rubella-specific IgG antibody and titres in recent HIV seroconvertors and in patients progressing to the AIDS-related complex and AIDS.
Thomas HI; Aird HC
J Med Virol; 1999 Jul; 58(3):273-9. PubMed ID: 10447423
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III.
Crapper RM; Frazer IH; Mackay IR; Iscaro A; Bradford DL
Concepts Immunopathol; 1987; 4():243-60. PubMed ID: 3297337
[No Abstract] [Full Text] [Related]
17. Reconstitution of immune function in AIDS/ARC.
Gottlieb AA; Gottlieb MS; Scholes VE
Concepts Immunopathol; 1987; 4():261-74. PubMed ID: 2954644
[No Abstract] [Full Text] [Related]
18. Immune defects and therapeutic approaches to immune reconstruction in AIDS/ARC.
Gottlieb AA
Lymphology; 1988 Mar; 21(1):66-9. PubMed ID: 2969439
[No Abstract] [Full Text] [Related]
19. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
[No Abstract] [Full Text] [Related]
20. Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.
Zolla-Pazner S; Des Jarlais DC; Friedman SR; Spira TJ; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5404-8. PubMed ID: 3496603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
